Al-Qaraghuli Sahar, Gache Yannick, Goncalves-Maia Maria, Alcor Damien, Muzotte Elodie, Mahfouf Walid, Rezvani Hamid-Reza, Magnaldo Thierry
INSERM U1081-CNRS UMR7284-UNS, CEDEX 02, F-06107 Nice, France.
Faculté de Médicine, 2ème étage, CNRS UMR 6267-INSERM U998-UNSA, F-06107 Nice Cedex 2, France.
Cancers (Basel). 2024 Sep 26;16(19):3277. doi: 10.3390/cancers16193277.
Xeroderma pigmentosum (XP) is a very rare recessive disease caused by the incapacity to resolve ultraviolet-induced DNA lesions through Nucleotide Excision Repair (NER). Most XP patients suffer from aggressive skin carcinoma and melanoma at a very early age (<8). Our previous results showed that primary XP fibroblasts isolated from healthy (non-photo-exposed) skin negatively impact the extracellular matrix and fail to activate the innate immune system. Here, we show for the first time that XP-C fibroblasts also play a major role in cancer cell invasion ex vivo and in vivo through the overexpression of Hepatocyte Growth Factor/Scatter Factor (HGF/SF) in the absence of genotoxic attacks. The use of inhibitors of the activation of the HGF/SF pathway counteracted the effects of XP fibroblasts on the growth of cancer cells, suggesting new perspectives in the care of XP patients.
着色性干皮病(XP)是一种非常罕见的隐性疾病,由核苷酸切除修复(NER)无法解决紫外线诱导的DNA损伤所致。大多数XP患者在很小的年龄(<8岁)就会患上侵袭性皮肤癌和黑色素瘤。我们之前的结果表明,从健康(未暴露于光)皮肤中分离出的原发性XP成纤维细胞会对细胞外基质产生负面影响,并且无法激活先天免疫系统。在这里,我们首次表明,在没有基因毒性攻击的情况下,XP-C成纤维细胞通过肝细胞生长因子/散射因子(HGF/SF)的过表达,在体外和体内的癌细胞侵袭中也发挥着重要作用。使用HGF/SF途径激活抑制剂可抵消XP成纤维细胞对癌细胞生长的影响,这为XP患者的治疗提供了新的视角。